NASDAQ · LMAT
LeMaitre Vascular, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for LMAT: Nov 04, 2026
LeMaitre Vascular, Inc. Common Stock is expected to report earnings on 11/04/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $0.69. The reported EPS for the same quarter last year was $0.62.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.69 | $0.69 | $0.69 | 3 |
| Dec 2026 | $0.78 | $0.79 | $0.77 | 3 |
| Mar 2027 | $0.74 | $0.74 | $0.74 | 1 |
| Jun 2027 | $0.83 | $0.83 | $0.83 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
BNK Invest · Zacks · The Motley Fool · MarketBeat- BNK Invest · Oct 5, 3:27 PM EDTNotable Monday Option Activity: LMAT, NXH, CWHLooking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in LeMaitre Vascular Inc (Symbol: LMAT), where a total volume of 1,875 contracts has been traded thus far today, a contract volume which is representative of approx
- Zacks · Sep 2, 11:40 AM EDTPAHC or LMAT: Which Is the Better Value Stock Right Now?PAHC vs. LMAT: Which Stock Is the Better Value Option?
- BNK Invest · Aug 19, 10:23 AM EDTReminder – LeMaitre Vascular (LMAT) Goes Ex-Dividend SoonLooking at the universe of stocks we cover at Dividend Channel, on 8/20/26, LeMaitre Vascular Inc (Symbol: LMAT) will trade ex-dividend, for its quarterly dividend of $0.25, payable on 9/3/26. As a percentage of LMAT's recent stock price of $82.75, this dividend works out to ap
- Zacks · Aug 13, 11:40 AM EDTGEHC or LMAT: Which Is the Better Value Stock Right Now?GEHC vs. LMAT: Which Stock Is the Better Value Option?
- The Motley Fool · Aug 11, 8:30 PM EDTLeMaitre Vascular (LMAT) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 4, 9:04 PM EDTLeMaitre Vascular Q2 Earnings Call HighlightsLeMaitre Vascular (NASDAQ:LMAT) reported second-quarter 2026 results marked by 10% organic revenue growth, record operating income and continued expansion of its Artegraft product line, while foreign exchange, Middle East export delays and cardiac allograft supply constraints wei
- Zacks · Aug 4, 7:00 PM EDTLeMaitre Vascular (LMAT) Q2 Earnings and Revenues Lag EstimatesLeMaitre (LMAT) delivered earnings and revenue surprises of -8.64% and -1.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jul 29, 8:25 AM EDTBoston Scientific (BSX) Surpasses Q2 Earnings and Revenue EstimatesBoston Scientific (BSX) delivered earnings and revenue surprises of +3.61% and +1.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 26, 9:53 AM EDTCasey's & 3 More Stocks With Strong Interest Coverage to Buy NowCASY, CLS, PNTG and LMAT stand out for strong interest coverage as borrowing costs rise, with solid sales/EPS growth estimates and big one-year gains.
- Zacks · May 25, 12:45 PM EDTLeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons WhyLeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.
- Zacks · May 13, 9:35 AM EDTDown 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a TurnaroundLeMaitre (LMAT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- BNK Invest · May 12, 4:05 PM EDTLeMaitre Vascular Enters Oversold TerritoryThe DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for LeMaitre Vascular, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.